Connection

KAVISH PATIDAR to Humans

This is a "connection" page, showing publications KAVISH PATIDAR has written about Humans.
Connection Strength

0.765
  1. Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 May; 10(5):418-430.
    View in: PubMed
    Score: 0.026
  2. Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology. 2025 Apr 01; 81(4):1256-1268.
    View in: PubMed
    Score: 0.025
  3. Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
    View in: PubMed
    Score: 0.024
  4. Editorial: Unmasking the silent threat-acute kidney injury in alcohol-associated hepatitis. Aliment Pharmacol Ther. 2024 01; 59(1):122-123.
    View in: PubMed
    Score: 0.024
  5. Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis. Hepatol Commun. 2023 12 01; 7(12).
    View in: PubMed
    Score: 0.024
  6. Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver Int. 2024 01; 44(1):241-249.
    View in: PubMed
    Score: 0.024
  7. Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2024 03 01; 30(3):244-253.
    View in: PubMed
    Score: 0.023
  8. Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis. Liver Transpl. 2024 02 01; 30(2):127-141.
    View in: PubMed
    Score: 0.023
  9. Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023 06; 57(12):1397-1406.
    View in: PubMed
    Score: 0.023
  10. Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective. Clin Gastroenterol Hepatol. 2023 04; 21(4):897-901.e1.
    View in: PubMed
    Score: 0.023
  11. The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 03 01; 29(3):246-258.
    View in: PubMed
    Score: 0.023
  12. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury. J Hepatol. 2022 07; 77(1):108-115.
    View in: PubMed
    Score: 0.021
  13. Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun. 2022 05; 6(5):1090-1099.
    View in: PubMed
    Score: 0.021
  14. Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
    View in: PubMed
    Score: 0.021
  15. Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol. 2020 09; 115(9):1505-1512.
    View in: PubMed
    Score: 0.019
  16. Associations Between Mean Arterial Pressure and Poor ICU Outcomes in Critically Ill Patients With Cirrhosis: Is 65 The Sweet Spot? Crit Care Med. 2020 09; 48(9):e753-e760.
    View in: PubMed
    Score: 0.019
  17. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020 11; 73(5):1092-1099.
    View in: PubMed
    Score: 0.019
  18. Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure. Dig Dis Sci. 2021 02; 66(2):619-627.
    View in: PubMed
    Score: 0.018
  19. Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis. Clin Transl Gastroenterol. 2019 09; 10(9):e00075.
    View in: PubMed
    Score: 0.018
  20. Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G447-G452.
    View in: PubMed
    Score: 0.018
  21. Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology. 2018 07; 68(1):224-233.
    View in: PubMed
    Score: 0.016
  22. No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients With Cirrhosis and Infections. Clin Gastroenterol Hepatol. 2017 11; 15(11):1803-1804.
    View in: PubMed
    Score: 0.015
  23. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci. 2017 05; 62(5):1173-1179.
    View in: PubMed
    Score: 0.015
  24. Tired of Hepatitis B? Dig Dis Sci. 2016 Apr; 61(4):953-4.
    View in: PubMed
    Score: 0.014
  25. Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2048-61.
    View in: PubMed
    Score: 0.013
  26. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014 Nov; 109(11):1757-63.
    View in: PubMed
    Score: 0.013
  27. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2014 Nov; 18(4):853-76.
    View in: PubMed
    Score: 0.013
  28. Antibiotics for the treatment of hepatic encephalopathy. Metab Brain Dis. 2013 Jun; 28(2):307-12.
    View in: PubMed
    Score: 0.011
  29. A cluster randomized trial of a Multicomponent Clinical Care Pathway (MCCP) to improve MASLD diagnosis and management in primary care: study protocol. BMC Health Serv Res. 2025 May 06; 25(1):645.
    View in: PubMed
    Score: 0.007
  30. Optimization and Protection of Kidney Health in Liver Transplant Recipients: Intra- and Postoperative Approaches. Transplantation. 2025 Jun 01; 109(6):938-944.
    View in: PubMed
    Score: 0.006
  31. Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
    View in: PubMed
    Score: 0.006
  32. Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
    View in: PubMed
    Score: 0.006
  33. Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis. Hepatol Commun. 2024 08 01; 8(8).
    View in: PubMed
    Score: 0.006
  34. Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
    View in: PubMed
    Score: 0.006
  35. Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Nov 01; 119(11):2259-2266.
    View in: PubMed
    Score: 0.006
  36. Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 2025 Feb 01; 31(2):170-180.
    View in: PubMed
    Score: 0.006
  37. The association between mean arterial pressure and acute kidney injury reversal among patients with decompensated cirrhosis. Hepatology. 2025 Jan 01; 81(1):126-135.
    View in: PubMed
    Score: 0.006
  38. From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury. Hepatology. 2025 Jun 01; 81(6):1878-1897.
    View in: PubMed
    Score: 0.006
  39. Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities. Transplantation. 2024 07 01; 108(7):1542-1550.
    View in: PubMed
    Score: 0.006
  40. Severe hepatic encephalopathy with mechanical ventilation may inform waitlist priority in acute liver failure: A UNOS database analysis. Clin Transplant. 2024 01; 38(1):e15215.
    View in: PubMed
    Score: 0.006
  41. Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. Am J Gastroenterol. 2024 02 01; 119(2):287-296.
    View in: PubMed
    Score: 0.006
  42. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol. 2023 12; 79(6):1408-1417.
    View in: PubMed
    Score: 0.006
  43. Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018. JAMA Netw Open. 2023 07 03; 6(7):e2324539.
    View in: PubMed
    Score: 0.006
  44. PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023 12 01; 78(6):1788-1799.
    View in: PubMed
    Score: 0.006
  45. Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant. J Cardiol. 2023 08; 82(2):113-121.
    View in: PubMed
    Score: 0.006
  46. Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study. Hepatol Commun. 2023 03 01; 7(3):e0058.
    View in: PubMed
    Score: 0.006
  47. Assessment of Vascular and Valvular Calcification Improves Screening for Coronary Artery Disease Before Liver Transplantation. Am J Cardiol. 2023 03 15; 191:23-31.
    View in: PubMed
    Score: 0.006
  48. Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis. Metab Brain Dis. 2023 06; 38(5):1749-1758.
    View in: PubMed
    Score: 0.006
  49. Hepatic Ischemia/Reperfusion Injury After Liver Transplantation Is Not Associated with Early Impairment of Left Ventricular Ejection Fraction. Ann Transplant. 2022 Dec 13; 27:e938105.
    View in: PubMed
    Score: 0.006
  50. Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1819-1830.e5.
    View in: PubMed
    Score: 0.005
  51. Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation. Liver Transpl. 2022 09; 28(9):1441-1453.
    View in: PubMed
    Score: 0.005
  52. Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist. J Viral Hepat. 2022 05; 29(5):366-374.
    View in: PubMed
    Score: 0.005
  53. Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022 06; 63(6):953-961.
    View in: PubMed
    Score: 0.005
  54. The kidney releases a nonpolymerizing form of uromodulin in the urine and circulation that retains the external hydrophobic patch domain. Am J Physiol Renal Physiol. 2022 04 01; 322(4):F403-F418.
    View in: PubMed
    Score: 0.005
  55. Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. Liver Transpl. 2022 02; 28(2):169-179.
    View in: PubMed
    Score: 0.005
  56. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
    View in: PubMed
    Score: 0.005
  57. Insight into an acute hepatitis A outbreak in Indiana. J Viral Hepat. 2021 06; 28(6):964-971.
    View in: PubMed
    Score: 0.005
  58. Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant. Clin Transplant. 2021 02; 35(2):e14190.
    View in: PubMed
    Score: 0.005
  59. Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis. Clin Transl Gastroenterol. 2020 12 17; 11(12):e00288.
    View in: PubMed
    Score: 0.005
  60. Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation. Ann Transplant. 2020 Nov 03; 25:e926453.
    View in: PubMed
    Score: 0.005
  61. Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. Am J Gastroenterol. 2020 11; 115(11):1849-1856.
    View in: PubMed
    Score: 0.005
  62. Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States. JAMA Netw Open. 2020 10 01; 3(10):e2019869.
    View in: PubMed
    Score: 0.005
  63. Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease. BMC Gastroenterol. 2020 Sep 16; 20(1):302.
    View in: PubMed
    Score: 0.005
  64. Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy. Dig Dis Sci. 2021 08; 66(8):2603-2609.
    View in: PubMed
    Score: 0.005
  65. Features of Blood Clotting on Thromboelastography in Hospitalized Patients With Cirrhosis. Am J Med. 2020 12; 133(12):1479-1487.e2.
    View in: PubMed
    Score: 0.005
  66. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metab Brain Dis. 2019 02; 34(1):289-295.
    View in: PubMed
    Score: 0.004
  67. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
    View in: PubMed
    Score: 0.003
  68. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. Am J Gastroenterol. 2016 Jan; 111(1):78-86.
    View in: PubMed
    Score: 0.003
  69. Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):402-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.